Apoptosis signals in sporadic amyotrophic lateral sclerosis: An immunocytochemical study

Acta Neuropathologica

Volumn 102, Issue 5, 2001, Pages 426-434

  Embacher, N ^a   Kaufmann, W A ^b   Beer, R ^a   Maier, H ^b   Jellinger, K A ^c   Poewe, W ^a   Ransmayr, G ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Amyotrophic lateral sclerosis; Apoptosis; Bak; Bax; Bcl 2

Indexed keywords

CASPASE 3; CELL PROTEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN CM 1; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; AUTOPSY; CELL COUNT; CELL DEATH; CELL LOSS; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MOTONEURON; MOTOR CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION; SPINAL CORD; TISSUE SECTION;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; FEMALE; FIXATIVES; FORMALDEHYDE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOTOR CORTEX; MOTOR NEURONS; PARAFFIN EMBEDDING; POLYMERS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SPINAL CORD;

EID: 0034771172     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010100438     Document Type: Article

References (56)

1. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease
2. Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry
3. Mitochondria and the pathogenesis of ALS
4. Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury
5. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS
6. Apoptosis in neuronal development and transplantation: Role of caspases and trophic factors
7. Mitochondrial enzyme activity in amyothrophic lateral sclerosis; Implications for the role of mitochondria in neuronal cell death
8. Neural apoptosis
9. Pathogenesis of amyotrophic lateral sclerosis: A critical review
10. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis
11. Induction of apoptosis by the Bcl-2 homologue Bak
12. Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease
13. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase
14. Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons
15. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG
16. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K
17. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene
18. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
19. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques
20. Mitochondria and apoptosis
21. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
22. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits
23. Neuropathology of ALS: An overview
24. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a lateral sclerosis mutant SOD1
25. Cell death mechanisms in Parkinson's disease
26. Mechanisms of cell death in neurodegenerative disorders
27. ALS
28. Cytoskeletal abnormalities in amyotrophic lateral sclerosis: Beneficial or detrimental effects?
29. Caspases cleave the amino-terminal calpain inhibitory unit of calpastatin during apoptosis in human jurkat T cells
30. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak
31. The proto-oncogene Bcl-2 and its role in regulating apoptosis
32. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ
33. Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
34. p53 is abnormally elevated and active in the CNS of patients with Amyotrophic Lateral Sclerosis
35. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death
36. Bcl-2 gene family in the nervous system
37. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS
38. Lack of apoptosis in mice with ALS
39. C-Jun, JNK/SAPK kinases and trascription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis
40. Amyotrophic lateral sclerosis: An introduction
41. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons
42. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
43. Evidence that Par-4 participates in motor neuron death in amyotrophic lateral sclerosis
44. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
45. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis
46. Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease
47. Detection of apoptosis in tissue sections
48. Increased caspase 3 and bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease
49. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus
50. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis
51. Delaying caspase activation by bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis
52. Calpain and caspase: Can you tell the difference?
53. Cell death and apoptosis regulating proteins in Parkinson's disease - A cautionary note
54. Cell death: The significance of apoptosis
55. Bcl-2 blocks glutamate toxicity in neural cell lines
56. Bcl-2 inhibits death of central neural cells induced by multiple agents